ANKHD1 as a regulator of JAK/STAT signalling. Version 1

• Research type

  Research Study

• Full title

  ANKHD1 as a clinically relevant regulator of JAK/STAT signalling in cancer. A descriptive study of ANKHD1 expression and STAT3 and STAT5 activity in myeloproliferative neoplasms and melanoma.

• IRAS ID

  111041

• Contact name

  Sally Thomas

• Contact email

  sally.thomas@doctors.org.uk

• Sponsor organisation

  Sheffield Teaching Hospitals NHS Trust

• REC name

  Yorkshire & The Humber - Bradford Leeds Research Ethics Committee

• REC reference

  13/YH/0018

• Date of REC Opinion

  21 Feb 2013

• REC opinion

  Further Information Favourable Opinion